L303-0913 Screening compound: 1-[4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(methylsulfanyl)phenyl]piperidine-4-carboxamide

L303-0913 Screening compound: 1-[4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(methylsulfanyl)phenyl]piperidine-4-carboxamide
L303-0913 Screening compound: 1-[4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(methylsulfanyl)phenyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L303-0913
1-[4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(methylsulfanyl)phenyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L303-0913

Molecular Formula

C24H26N4O4S2 (C24 H26 N4 O4 S2)

Compound Name

1-[4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(methylsulfanyl)phenyl]piperidine-4-carboxamide

IUPAC name

1-[4-(5-cyclopropyl-124-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(methylsulfanyl)phenyl]piperidine-4-carboxamide

SMILES

CSc1cccc(NC(C(CC2)CCN2S(c(cc2)ccc2-c2noc(C3CC3)n2)(=O)=O)=O)c1

InChI

InChI=1S/C24H26N4O4S2/c1-33-20-4-2-3-19(15-20)25-23(29)17-11-13-28(14-12-17)34(30,31)21-9-7-16(8-10-21)22-26-24(32-27-22)18-5-6-18/h2-4,7-10,15,17-18H,5-6,11-14H2,1H3,(H,25,29)

InChI Key

HFUVXVKJTJYACB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15123344

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

498.63

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.651

Distribution Coefficient, logD

4.651

Water Solubility, LogSw

-4.33

Polar Surface Area

86.970

Acid Dissociation Constant (pKa)

11.89

Base Dissociation Constant (pKb)

0.53

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

L303-0913 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with L303-0913 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L303-0913?
Check Price and Availability of L303-0913, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L303-0913 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L303-0913
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L303-0913
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L303-0913 available by request